Approach to treatment of medical and cosmetic facial concerns in skin of color patients.

Facial concerns in skin of color (SOC) patients vary and can be a source of emotional and psychological distress. This article discusses 4 common facial concerns in SOC patients: acne, rosacea, facial hyperpigmentation, and cosmetic enhancement. Treatment recommendations are provided as well as management pearls.

[1]  S. Feldman,et al.  Oxymetazoline hydrochloride cream for facial erythema associated with rosacea , 2017, Expert review of clinical pharmacology.

[2]  R. Mehta,et al.  Development and Clinical Assessment of a Comprehensive Product for Pigmentation Control in Multiple Ethnic Populations. , 2016, Journal of drugs in dermatology : JDD.

[3]  T. Thng,et al.  Oral tranexamic acid (TA) in the treatment of melasma: A retrospective analysis. , 2016, Journal of the American Academy of Dermatology.

[4]  L. Sperling,et al.  Diagnostic Clues to Frontal Fibrosing Alopecia in Patients of African Descent. , 2016, The Journal of clinical and aesthetic dermatology.

[5]  M. Nodzenski,et al.  Nonablative Fractional Laser Resurfacing for Acne Scarring in Patients With Fitzpatrick Skin Phototypes IV-VI , 2016, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[6]  C. Burgess,et al.  Ethnic and Gender Considerations in the Use of Facial Injectables: African-American Patients , 2015, Plastic and reconstructive surgery.

[7]  Sandra M. Johnson,et al.  The role of brimonidine tartrate gel in the treatment of rosacea , 2015, Clinical, cosmetic and investigational dermatology.

[8]  Vladyslava Doktor,et al.  Update on the Management of Rosacea , 2015, Plastic surgical nursing : official journal of the American Society of Plastic and Reconstructive Surgical Nurses.

[9]  S. Dogra,et al.  Minocycline for Recurrent and/or Chronic Erythema Nodosum Leprosum. , 2015, JAMA dermatology.

[10]  H. Sundaram,et al.  Safety of Microfocused Ultrasound With Visualization in Patients With Fitzpatrick Skin Phototypes III to VI. , 2015, JAMA facial plastic surgery.

[11]  S. Davis,et al.  Rosacea in skin of color: not a rare diagnosis. , 2014, Dermatology online journal.

[12]  H. Miot,et al.  Melasma: a clinical and epidemiological review* , 2014, Anais brasileiros de dermatologia.

[13]  M. Goldman,et al.  Retrospective Evaluation of Micro‐focused Ultrasound for Lifting and Tightening the Face and Neck , 2014, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[14]  J. P. Castanedo-Cázares,et al.  Near‐visible light and UV photoprotection in the treatment of melasma: a double‐blind randomized trial , 2014, Photodermatology, photoimmunology & photomedicine.

[15]  V. Garg,et al.  Chemical Peels for Melasma in Dark-Skinned Patients , 2012, Journal of cutaneous and aesthetic surgery.

[16]  S. Davis,et al.  Top dermatologic conditions in patients of color: an analysis of nationally representative data. , 2012, Journal of drugs in dermatology : JDD.

[17]  J. Levin,et al.  Aesthetic Dermatology for Aging Ethnic Skin , 2012 .

[18]  J. D. Del Rosso.  Advances in understanding and managing rosacea: part 1: connecting the dots between pathophysiological mechanisms and common clinical features of rosacea with emphasis on vascular changes and facial erythema. , 2012, The Journal of clinical and aesthetic dermatology.

[19]  G. Hillebrand,et al.  Comparison of the epidemiology of acne vulgaris among Caucasian, Asian, Continental Indian and African American women , 2011, Journal of the European Academy of Dermatology and Venereology : JEADV.

[20]  L. Kircik.  Efficacy and safety of azelaic acid (AzA) gel 15% in the treatment of post-inflammatory hyperpigmentation and acne: a 16-week, baseline-controlled study. , 2011, Journal of drugs in dermatology : JDD.

[21]  Erica C Davis,et al.  Postinflammatory hyperpigmentation: a review of the epidemiology, clinical features, and treatment options in skin of color. , 2010, The Journal of clinical and aesthetic dermatology.

[22]  C. Burgess,et al.  Considerations for the use of injectable poly-L-lactic acid in people of color. , 2010, Journal of drugs in dermatology : JDD.

[23]  V. Callender,et al.  A review of acne in ethnic skin: pathogenesis, clinical manifestations, and management strategies. , 2010, The Journal of clinical and aesthetic dermatology.

[24]  M. Gold.  A Four-Month Randomized, Double-Blind Evaluation of the Efficacy of Botulinum Toxin Type A for the Treatment of Glabellar Lines in Women with Skin Types V and VI , 2010 .

[25]  Susan C. Taylor,et al.  Safety of Nonanimal Stabilized Hyaluronic Acid Dermal Fillers in Patients with Skin of Color: A Randomized, Evaluator‐Blinded Comparative Trial , 2009, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[26]  Susan C. Taylor,et al.  Six‐Month Safety Results of Calcium Hydroxylapatite for Treatment of Nasolabial Folds in Fitzpatrick Skin Types IV to VI , 2009, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[27]  N. Scheinfeld,et al.  Rosacea: a review. , 2009, P & T : a peer-reviewed journal for formulary management.

[28]  S. Feldman,et al.  Prevalence of pigmentary disorders and their impact on quality of life: a prospective cohort study , 2008, Journal of cosmetic dermatology.

[29]  Susan C. Taylor,et al.  Common dermatologic disorders in skin of color: a comparative practice survey. , 2007, Cutis.

[30]  Mary P Lupo.  Dermatosis papulosis nigra: treatment options. , 2007, Journal of drugs in dermatology : JDD.

[31]  C. Burgess.  Soft tissue augmentation in skin of color: market growth, available fillers, and successful techniques. , 2007, Journal of drugs in dermatology : JDD.

[32]  P. Grimes,et al.  Tazarotene cream for postinflammatory hyperpigmentation and acne vulgaris in darker skin: a double-blind, randomized, vehicle-controlled study. , 2006, Cutis.

[33]  J. Lear,et al.  Postinflammatory hyperpigmentation in an Asian patient: a dramatic response to oral isotretinoin (13‐cis‐retinoic acid) , 2005, The British journal of dermatology.

[34]  V. Callender.  Acne in ethnic skin: special considerations for therapy , 2004, Dermatologic therapy.

[35]  R. Katta,et al.  Diltiazem-induced photodistributed hyperpigmentation. , 2003, Dermatology online journal.

[36]  R. Halder,et al.  Acne in ethnic skin. , 2003, Dermatologic clinics.

[37]  Susan C. Taylor,et al.  Efficacy and safety of a new triple-combination agent for the treatment of facial melasma. , 2003, Cutis.

[38]  Susan C. Taylor,et al.  Acne vulgaris in skin of color. , 2002, Journal of the American Academy of Dermatology.

[39]  W. Jacyk,et al.  Adapalene in the treatment of African patients , 2001, Journal of the European Academy of Dermatology and Venereology : JEADV.

[40]  P. Grimes.  Skin and hair cosmetic issues in women of color. , 2000, Dermatologic clinics.

[41]  A. Pandya,et al.  Disorders of hyperpigmentation. , 2000, Dermatologic clinics.

[42]  G. M. White.  Recent findings in the epidemiologic evidence, classification, and subtypes of acne vulgaris. , 1998, Journal of the American Academy of Dermatology.

[43]  P. Grimes.  Melasma. Etiologic and therapeutic considerations. , 1995, Archives of dermatology.

[44]  T. Hamilton,et al.  Topical tretinoin (retinoic acid) therapy for hyperpigmented lesions caused by inflammation of the skin in black patients. , 1993, The New England journal of medicine.

[45]  P. Grimes,et al.  Dermatosis papulosa nigra. , 1983, Cutis.

[46]  P. Grimes,et al.  Incidence of common dermatoses in a predominantly black dermatologic practice. , 1983, Cutis.

[47]  A. Kligman,et al.  "Acne cosmetica". , 1972, Archives of dermatology.

[48]  J. E. Fulton,et al.  Pomade acne. , 1970, Archives of dermatology.